164 related articles for article (PubMed ID: 27328305)
1. CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish.
Saltari A; Truzzi F; Quadri M; Lotti R; Palazzo E; Grisendi G; Tiso N; Marconi A; Pincelli C
J Invest Dermatol; 2016 Oct; 136(10):2049-2058. PubMed ID: 27328305
[TBL] [Abstract][Full Text] [Related]
2. low neurotrophin receptor CD271 regulates phenotype switching in melanoma.
Restivo G; Diener J; Cheng PF; Kiowski G; Bonalli M; Biedermann T; Reichmann E; Levesque MP; Dummer R; Sommer L
Nat Commun; 2017 Dec; 8(1):1988. PubMed ID: 29215016
[TBL] [Abstract][Full Text] [Related]
3. CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug.
Chung MK; Jung YH; Lee JK; Cho SY; Murillo-Sauca O; Uppaluri R; Shin JH; Sunwoo JB
Clin Cancer Res; 2018 Feb; 24(3):674-683. PubMed ID: 29208672
[No Abstract] [Full Text] [Related]
4. CD271 determines migratory properties of melanoma cells.
Radke J; Roßner F; Redmer T
Sci Rep; 2017 Aug; 7(1):9834. PubMed ID: 28852061
[TBL] [Abstract][Full Text] [Related]
5. Harnessing autophagy to overcome mitogen-activated protein kinase kinase inhibitor-induced resistance in metastatic melanoma.
Verykiou S; Alexander M; Edwards N; Plummer R; Chaudhry B; Lovat PE; Hill DS
Br J Dermatol; 2019 Feb; 180(2):346-356. PubMed ID: 30339727
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-Inducible Factor-1α and CD271 inversely correlate with melanoma invasiveness.
Marconi A; Borroni RG; Truzzi F; Longo C; Pistoni F; Pellacani G; Pincelli C
Exp Dermatol; 2015 May; 24(5):396-8. PubMed ID: 25739328
[TBL] [Abstract][Full Text] [Related]
7. CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes.
Quadri M; Tiso N; Musmeci F; Morasso MI; Brooks SR; Bonetti LR; Panini R; Lotti R; Marconi A; Pincelli C; Palazzo E
J Exp Clin Cancer Res; 2023 Jul; 42(1):167. PubMed ID: 37443031
[TBL] [Abstract][Full Text] [Related]
8. Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma Progression.
Saltari A; Dzung A; Quadri M; Tiso N; Facchinello N; Hernández-Barranco A; Garcia-Silva S; Nogués L; Stoffel CI; Cheng PF; Turko P; Eichhoff OM; Truzzi F; Marconi A; Pincelli C; Peinado H; Dummer R; Levesque MP
Cancer Res; 2021 Dec; 81(23):6044-6057. PubMed ID: 34645608
[TBL] [Abstract][Full Text] [Related]
9. The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells.
Redmer T; Welte Y; Behrens D; Fichtner I; Przybilla D; Wruck W; Yaspo ML; Lehrach H; Schäfer R; Regenbrecht CR
PLoS One; 2014; 9(5):e92596. PubMed ID: 24799129
[TBL] [Abstract][Full Text] [Related]
10. CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to Tumorigenicity.
Boyle SE; Fedele CG; Corbin V; Wybacz E; Szeto P; Lewin J; Young RJ; Wong A; Fuller R; Spillane J; Speakman D; Donahoe S; Pohl M; Gyorki D; Henderson MA; Johnstone RW; Papenfuss AT; Shackleton M
Cancer Res; 2016 Jul; 76(13):3965-77. PubMed ID: 27325642
[TBL] [Abstract][Full Text] [Related]
11. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271.
Boiko AD; Razorenova OV; van de Rijn M; Swetter SM; Johnson DL; Ly DP; Butler PD; Yang GP; Joshua B; Kaplan MJ; Longaker MT; Weissman IL
Nature; 2010 Jul; 466(7302):133-7. PubMed ID: 20596026
[TBL] [Abstract][Full Text] [Related]
12. CD271 on melanoma cell is an IFN-γ-inducible immunosuppressive factor that mediates downregulation of melanoma antigens.
Furuta J; Inozume T; Harada K; Shimada S
J Invest Dermatol; 2014 May; 134(5):1369-1377. PubMed ID: 24226422
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical CD271 expression correlates with melanoma progress in a case-control study.
Nielsen PS; Riber-Hansen R; Steiniche T
Pathology; 2018 Jun; 50(4):402-410. PubMed ID: 29678478
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-2 promotes melanoma growth and progression in vivo.
Moriarty WF; Kim E; Gerber SA; Hammers H; Alani RM
Melanoma Res; 2016 Aug; 26(4):321-8. PubMed ID: 26881875
[TBL] [Abstract][Full Text] [Related]
15. Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma.
Gambichler T; Petig AL; Stockfleth E; Stücker M
Clin Exp Dermatol; 2016 Oct; 41(7):709-16. PubMed ID: 27663144
[TBL] [Abstract][Full Text] [Related]
16. Tumor stem cells (CD271, c-kit, SOX10) in Melanomas: prognostic and outcome implications.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2014; 22(2):142-5. PubMed ID: 23958542
[TBL] [Abstract][Full Text] [Related]
17. CD271 is expressed in melanomas with more aggressive behaviour, with correlation of characteristic morphology by in vivo reflectance confocal microscopy.
Beretti F; Manni P; Longo C; Argenziano G; Farnetani F; Cesinaro AM; Witkowski AM; De Pol A; Pellacani G
Br J Dermatol; 2015 Mar; 172(3):662-8. PubMed ID: 25066225
[TBL] [Abstract][Full Text] [Related]
18. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth.
Civenni G; Walter A; Kobert N; Mihic-Probst D; Zipser M; Belloni B; Seifert B; Moch H; Dummer R; van den Broek M; Sommer L
Cancer Res; 2011 Apr; 71(8):3098-109. PubMed ID: 21393506
[TBL] [Abstract][Full Text] [Related]
19. Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line.
Chandrasekaran S; DeLouise LA
Biomaterials; 2011 Dec; 32(35):9316-27. PubMed ID: 21917310
[TBL] [Abstract][Full Text] [Related]
20. Do DLX3 and CD271 Protect Human Keratinocytes from Squamous Tumor Development?
Palazzo E; Marconi A; Pincelli C; Morasso MI
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31331058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
